JTC H1 profit falls 63% as revenue rises 17%; acquisitions drive growth

JTC Plc reported a 62.6% decline in first-half reported profit to £6.9 million, primarily due to acquisition costs and share-based payments, despite a 17.3% increase in revenue to £172.6 million and a 15.1% rise in underlying EBITDA to £56.5 million. The professional services firm highlighted strong organic growth and record new business wins, providing over £2.4 billion in future revenue visibility, and declared an increased interim dividend of 5 pence per share. While net debt rose to £250.7 million, pushing leverage slightly above its target range, JTC affirmed its full-year expectations and announced further strategic acquisitions aimed at future earnings accretion.

Analysis

JTC Plc's first-half results present a clear divergence between reported and underlying performance, driven by its active acquisition strategy. While statutory profit fell sharply by 62.6% to £6.9 million, this was primarily due to acquisition costs and share-based payments. The firm's operational health appears robust, as evidenced by a 17.3% increase in revenue to £172.6 million and a 15.1% rise in underlying EBITDA to £56.5 million. This growth was fueled by strong net organic growth of 11% and record new business wins, which provide long-term revenue visibility exceeding £2.4 billion. However, this M&A-led growth has impacted the balance sheet, with net debt increasing to £250.7 million and leverage rising to 2.06 times underlying EBITDA, slightly above the company's target range of 1.5-2.0x. Management's confidence is signaled by a 16.3% increase in the interim dividend and the reaffirmation of full-year guidance, suggesting the acquisition costs were anticipated. The ongoing strategy includes the post-period completion of the Citi Trust deal and the proposed purchase of Kleinwort Hambros, which is expected to be earnings accretive in 2026.

Key Decisions for Investors

• Investors should look past the steep drop in reported profit and focus on the 15.1% growth in underlying EBITDA and strong 11% net organic revenue growth as more accurate measures of the company's operational health.
• It is crucial to monitor the balance sheet, as leverage at 2.06x underlying EBITDA has breached the company's target range, making the successful integration and cash generation of recent acquisitions a key factor for future performance.
• The 16.3% dividend increase and reaffirmed full-year guidance are strong confidence signals, but the investment case relies on management's ability to execute on its M&A strategy and deliver the promised earnings accretion from its acquisition pipeline.